Free Trial

Adagio Medical (ADGM) Competitors

Adagio Medical logo
$1.31 -0.03 (-2.24%)
Closing price 04:00 PM Eastern
Extended Trading
$1.32 +0.01 (+1.15%)
As of 05:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADGM vs. CNDA, SPKL, DSAQ, NBST, BKHA, NOEM, BIOX, LFT, PCSC, and DTSQ

Should you be buying Adagio Medical stock or one of its competitors? The main competitors of Adagio Medical include Concord Acquisition Corp II (CNDA), Spark I Acquisition (SPKL), Direct Selling Acquisition (DSAQ), Newbury Street Acquisition (NBST), Black Hawk Acquisition (BKHA), CO2 Energy Transition (NOEM), Bioceres Crop Solutions (BIOX), Lument Finance Trust (LFT), Perceptive Capital Solutions (PCSC), and DT Cloud Star Acquisition (DTSQ). These companies are all part of the "trading" industry.

Adagio Medical vs. Its Competitors

Concord Acquisition Corp II (NYSE:CNDA) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Concord Acquisition Corp II's return on equity of -31.47% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Concord Acquisition Corp IIN/A -31.47% -1.34%
Adagio Medical N/A -248.26%-125.31%

Concord Acquisition Corp II has higher earnings, but lower revenue than Adagio Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concord Acquisition Corp IIN/AN/A$6.96MN/AN/A
Adagio Medical$600K33.58-$75.04MN/AN/A

In the previous week, Adagio Medical had 1 more articles in the media than Concord Acquisition Corp II. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for Concord Acquisition Corp II. Concord Acquisition Corp II's average media sentiment score of 0.00 equaled Adagio Medical'saverage media sentiment score.

Company Overall Sentiment
Concord Acquisition Corp II Neutral
Adagio Medical Neutral

48.1% of Adagio Medical shares are owned by institutional investors. 0.5% of Concord Acquisition Corp II shares are owned by insiders. Comparatively, 53.5% of Adagio Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Concord Acquisition Corp II has a beta of 0.02, meaning that its share price is 98% less volatile than the S&P 500. Comparatively, Adagio Medical has a beta of 0.17, meaning that its share price is 83% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concord Acquisition Corp II
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Adagio Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Adagio Medical beats Concord Acquisition Corp II on 6 of the 9 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADGM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADGM vs. The Competition

MetricAdagio MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$20.61M$7.57B$6.19B$10.60B
Dividend YieldN/A1.13%5.72%4.86%
P/E RatioN/A27.3229.6428.46
Price / Sales33.5827.88577.46128.87
Price / CashN/A22.5936.5560.64
Price / Book1.005.2512.076.53
Net Income-$75.04M$178.09M$3.32B$276.75M
7 Day Performance-11.49%-0.42%-0.16%0.20%
1 Month Performance-35.47%1.15%5.76%1.67%
1 Year Performance-51.48%2.87%65.71%32.73%

Adagio Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADGM
Adagio Medical
0.438 of 5 stars
$1.31
-2.2%
N/A-51.8%$20.61M$600K0.0087
CNDA
Concord Acquisition Corp II
N/A$11.42
flat
N/AN/A$105.10MN/A0.002Upcoming Earnings
SPKL
Spark I Acquisition
N/A$11.52
-0.3%
N/A+7.3%$99.76MN/A0.00N/APositive News
DSAQ
Direct Selling Acquisition
N/A$11.69
flat
N/AN/A$99.04MN/A0.003
NBST
Newbury Street Acquisition
N/A$20.00
flat
N/AN/A$98.98MN/A0.002Positive News
Short Interest ↓
BKHA
Black Hawk Acquisition
N/A$11.03
-2.4%
N/A+9.2%$98.50MN/A0.00N/APositive News
Short Interest ↓
NOEM
CO2 Energy Transition
N/A$10.19
+0.1%
N/AN/A$97.72MN/A0.00N/APositive News
BIOX
Bioceres Crop Solutions
2.4029 of 5 stars
$1.54
+9.2%
$4.17
+170.6%
-73.7%$96.57M$333.30M-1.90500News Coverage
Analyst Downgrade
Short Interest ↑
High Trading Volume
LFT
Lument Finance Trust
1.5117 of 5 stars
$1.83
+2.5%
N/A-30.1%$95.52M$122.13M9.61600
PCSC
Perceptive Capital Solutions
N/A$10.64
+0.1%
N/A+6.1%$94.80MN/A0.00N/APositive News
High Trading Volume
DTSQ
DT Cloud Star Acquisition
N/A$10.48
+0.1%
N/AN/A$93.27MN/A0.00N/A

Related Companies and Tools


This page (NASDAQ:ADGM) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners